7
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11228 |
ERK2 IN-1
|
ERK | MAPK |
ERK2 IN-1 is a selective ERK2 inhibitor with an IC50 of 7 nM. | |||
T2310L |
CHIR-99021 HCl
CT99021 HCl,Laduviglusib HCl |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
CHIR-99021 HCl (Laduviglusib HCl) 是GSK-3α/β的高效选择性抑制剂,IC50值分别为10 nM和6.7 nM。它对GSK-3表现出显著的选择性,对CDC2、ERK2和其他蛋白激酶的选择性超过500倍。此外,CHIR-99021 HCl 是Wnt/β-catenin信号通路的强大激活剂。此外,它在小鼠和人类胚胎干细胞中都表现出增强自我更新的能力。此外,拉杜维格西单盐酸盐诱导自噬[1][2][3]。 | |||
T76556 |
MEK1 Derived Peptide Inhibitor 1
|
||
MEK1Derived Peptide Inhibitor 1,一种肽抑制剂,以IC50值30 μM抑制MEK1激活ERK2。适用于细胞渗透性研究。 | |||
T11225 |
ERK-IN-2
|
ERK | MAPK |
ERK-IN-2 是ERK2抑制剂,IC50值为 1.8 nM。 ERK-IN-2 在剂量 >10 μM 可能引起脱靶毒性和/或脱靶活性。 | |||
T81387 |
Prosaptide Tx14(A) TFA
|
||
Prosaptide Tx14(A) TFA 为prosaposin衍生的肽类化合物,可有效激活GPR37L1及GPR37,其EC50值分别为5 nM与7 nM。该化合物亦能促进Schwann细胞内ERK1与ERK2的磷酸化作用。 | |||
T61755 |
E6201
|
||
E6201 (ER-806201) is a potent dual kinase inhibitor targeting MEK1 and FLT3, inhibiting their activities in an ATP-competitive manner. It effectively suppresses MEK1-induced ERK2 phosphorylation (IC50 = 5.2 nM), MKK4-induced JNK phosphorylation (IC50 = 91 nM), and MKK6-induced p38 MAPK phosphorylation (IC50 = 19 nM). E6201 exhibits anti-tumor and anti-psoriasis effects [1] [2]. | |||
T38377 |
ADTL-EI1712
ADTL-EI1712 |
||
ADTL-EI1712 is a dual inhibitor of ERK1 and ERK5 (IC50s = 40.43 and 64.5 nM, respectively).1It reduces ERK1 and ERK5 activity by 93.5% and 89.4%, respectively, but also inhibits ERK2 activity by 92.7%, in a panel of 100 kinases at 1 μM. ADTL-EI1712 inhibits proliferation of HL-60 and MKN74, but not HeLa, cancer cells (IC50s = 1.26, 2.55, and >50 μM, respectively). It reduces tumor growth and intratumor phosphorylation of ERK1/2 and ERK5 in an MKN74 mouse xenograft model when administered at a do... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6S0655 |
Corynoxeine
|
ERK | MAPK |
Corynoxeine 是从钩藤中分离的一种天然产物,是 PDGF-BB 诱导血管平滑肌细胞 (VSMCs) 增殖过程中的 ERK1/ERK2抑制剂。 |